Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase
- PMID: 4210249
- DOI: 10.1016/0022-4731(74)90126-5
Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase
Abstract
PIP: It is known that most carcinogenic chemicals can be bound irreversibly to proteins or nucleic acids. A study is presented that explored the irreversible binding of 17alpha-ethinyl estradiol to proteins and nucleic acids by the catalytic action of rat liver microsomes and muschroom tyrosinase. The microsomal binding reaction was inhibited by glutathione and cysteine and its derivatives though it was not affected by lysine and amines. Binding reactivity in the tyrosinase system was inhibited by glutathione, cysteine and its derivates, lysine, and amines. Polylysine did not bind the metabolite of ethinyl estradiol, which suggests the NH2 groups do not bind to the intermediate in the microsomal reaction. However, polylysine did bind irreversibly with esthinyl estradiol metabolites in tyrosinase catalysis. The nonenzymatic reaction of 17beta-hydroxy-4,10(1)-estradiene-2,3-dione with cysteine, lysine, and lysine derivates was found to support the thesis that estrogen o-quinones are the intermediates involved in the protein binding of estrogens in tyrosinase catalysis. An irreversible binding of ethinyl estradiol to DNA and RNA occurred with tyrosinase but not with rat liver microsomes. It was concluded that the results of rat liver microsome catalysis make it unlikely that estrogens are chemical carcinogens.
Similar articles
-
Proceedings: Catalysis of the covalent binding of estrogens to macromolecules by liver microsomes as compared with the model enzyme tyrosinase.Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R45. Naunyn Schmiedebergs Arch Pharmacol. 1974. PMID: 4276581 No abstract available.
-
The carcinogenic activity of ethinyl estrogens is determined by both their hormonal characteristics and their conversion to catechol metabolites.Endocrinology. 1993 Feb;132(2):577-83. doi: 10.1210/endo.132.2.8381068. Endocrinology. 1993. PMID: 8381068
-
Estrogen metabolism in rat liver microsomal and isolated hepatocyte preparations--II. Inhibition studies.J Steroid Biochem. 1984 Dec;21(6):709-16. doi: 10.1016/0022-4731(84)90035-9. J Steroid Biochem. 1984. PMID: 6527535
-
Selected aspects of the pharmacokinetics and metabolism of ethinyl estrogens and their clinical implications.Am J Obstet Gynecol. 1990 Jul;163(1 Pt 2):318-22. doi: 10.1016/0002-9378(90)90575-r. Am J Obstet Gynecol. 1990. PMID: 2196804 Review.
-
Entabolons: How Metabolites Modify the Biochemical Function of Proteins and Cause the Correlated Behavior of Proteins in Pathways.J Chem Inf Model. 2025 Jun 9;65(11):5785-5800. doi: 10.1021/acs.jcim.5c00462. Epub 2025 May 16. J Chem Inf Model. 2025. PMID: 40378093 Free PMC article. Review.
Cited by
-
Metabolic activation of acetylenic substituents to derivatives in the rat causing the loss of hepatic cytochrome P-450 and haem.Biochem J. 1978 Sep 15;174(3):853-61. doi: 10.1042/bj1740853. Biochem J. 1978. PMID: 728091 Free PMC article.
-
Metabolism of stilbene estrogens and steroidal estrogens in relation to carcinogenicity.Arch Toxicol. 1984 Jul;55(2):104-9. doi: 10.1007/BF00346047. Arch Toxicol. 1984. PMID: 6383273 Review.
-
Covalent binding of drug metabolites to DNA--a tool of predictive value?Arch Toxicol. 1980 Nov;46(1-2):171-80. doi: 10.1007/BF00361255. Arch Toxicol. 1980. PMID: 7235993
-
The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites.Br J Clin Pharmacol. 1987 Apr;23(4):447-53. doi: 10.1111/j.1365-2125.1987.tb03074.x. Br J Clin Pharmacol. 1987. PMID: 3555579 Free PMC article.
-
Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.Biochem J. 1977 Jul 15;166(1):57-64. doi: 10.1042/bj1660057. Biochem J. 1977. PMID: 901418 Free PMC article.